ITMCTR1900002343Not yet recruiting未知
A prospective randomized controlled trial of Xiaoyu in the treatment of Mastalgia
Guangdong Provincial Hospital of TCM0 sitesStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Not yet recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional study
Eligibility Criteria
- Ages
- 20 to 55 (—)
- Sex
- Female
Inclusion Criteria
- •1. Aged between 20-55 years old;
- •2. Comply with the diagnostic criteria for mammary gland hyperplasia (Mastalgia);
- •3. The first diagnosis of breast pain or an untreated patient for at least 6 months;
- •4. The course of disease has been more than 3 months;
- •5. The degree of pain was visual analogue scale (VAS) I:5-8;
- •6. Patients willing to participate in the RCT and sign informed consent forms.
Exclusion Criteria
- •1. Mastitis patients;
- •2. Suspected or confirmed breast cancer;
- •3. With breast fibroadenomas and other neoplastic diseases;
- •4. Pregnant or nearly 3 months with birth planning and lactating women;
- •5. Combined with serious primary diseases such as cardiovascular, cerebrovascular, hepatic, renal and hematopoietic systems, and mental patients;
- •6. Patients with irregular menstrual cyclessuch as polycystic ovary syndrome, adenomyosis and other patients.
Investigators
Similar Trials
Not yet recruiting
Phase 1
A prospective randomized controlled trial for Yan's Jiangzhi Decoction Combined with atorvastatin in the treatment of dyslipidemia complicated with carotid atherosclerosisdyslipidemiacarotid atherosclerosisITMCTR2000003687Shanghai Tenth People's Hospital
Recruiting
Phase 1
A randomized controlled trial for Yi-Sheng Xiao-Zheng granules in the treatment of dysmenorrhea caused by pelvic endometriosis (syndrome of kidney deficiency and blood stasis)EndometriosisITMCTR1900002773Dongfang Hospital of Beijing University of Chinese Medicine
Not yet recruiting
Not Applicable
A randomized controlled trial for 'Xing-Nao Kai-Qiao' Rehabilitation Program in the Treatment of Motor Aphasia after StrokeAphasia after StrokeITMCTR1900002688The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
Not yet recruiting
Not Applicable
A randomized controlled trial evaluating the jiangniaosuan formulation as a treatment for hyperuricemic nephropathy at CKD stages 3-4 patientshyperuricemic nephropathy at CKD stages 3-4ITMCTR2100005088Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Not yet recruiting
Phase 1
A randomized controlled trial for Xiao-Qing-Long Decoction in the treatment of refractory asthmarefractory asthmaITMCTR1900002783Hospital of Chengdu University of Traditional Chinese Medicine